Results 1 to 10 of about 1,090,450 (263)
Human Vaccines & Immunotherapeutics, 2020 Simultaneous administration of different vaccines is a strategy to increase the possibility to receive vaccines at appropriate age, safely and effectively, reducing the number of sessions and allowing a more acceptable integration of new vaccines into ...
Paolo Bonanni +6 more
doaj +2 more sources
Vaccines against Meningococcal Diseases
Microorganisms, 2020 Neisseria meningitidis is the main cause of meningitis and sepsis, potentially life-threatening conditions. Thanks to advancements in vaccine development, vaccines are now available for five out of six meningococcal disease-causing serogroups (A, B, C, W,
Mariagrazia Pizza +2 more
doaj +2 more sources
Current Scientific Advances in Vaccines Against UTIs: Challenges and Prospects [PDF]
MicroorganismsUrinary Tract Infection (UTI), the second most common infectious disease globally, poses a particularly significant threat to adult female populations. Epidemiological data show that Uropathogenic Escherichia coli (UPEC) is responsible for approximately ...
Baoying Wang +8 more
doaj +2 more sources
Carbohydrate—protein conjugate vaccines [PDF]
Clinical Microbiology and Infection, 2003 Various pathogenic bacteria have coats of polysaccharide, many with repeating epitopes. Though polysaccharide vaccines have been available for some time, they induce mainly IgM production, and are only moderately protective in adults and ineffective in ...
Ada, G., Isaacs, D.
core +5 more sources
Evaluation of the Induction of Immune Memory following Infant Immunisation with Serogroup C Neisseria meningitidis Conjugate Vaccines - Exploratory Analyses within a Randomised Controlled Trial [PDF]
, 2014 Aim: We measured meningococcal serogroup C (MenC)-specific memory B-cell responses in infants by Enzyme-Linked Immunospot (ELISpot) following different MenC conjugate vaccine schedules to investigate the impact of priming on immune memory.
Birks, Jacqueline +7 more
core +20 more sources
Infant protection from invasive Haemophilus influenzae type b disease using the PRP-OMPC conjugate vaccine: An update [PDF]
Human Vaccines & ImmunotherapeuticsInvasive disease caused by Haemophilus influenzae type b (Hib) is a major health concern, particularly in children under 5 years of age and vulnerable populations.
Muhamed-Kheir Taha +5 more
doaj +2 more sources
Strengths and weaknesses of pneumococcal conjugate vaccines
Glycoconjugate Journal, 2023 Multivalent vaccines addressing an increasing number of Streptococcus pneumoniae types (7-, 10-, 13-, 15-, 20-valent) have been licensed over the last 22 years.
F. Micoli +4 more
semanticscholar +1 more source
ACS Infectious Diseases, 2023 The surface of cells is coated with a dense layer of glycans, known as the cell glycocalyx. The complex glycans in the glycocalyx are involved in various biological events, such as bacterial pathogenesis, protection of bacteria from environmental ...
Rajendra S Rohokale, Zhongwu Guo
semanticscholar +1 more source
Emerging Infectious Diseases, 2022 We evaluated invasive pneumococcal disease (IPD) during 8 years of infant pneumococcal conjugate vaccine (PCV) programs using 10-valent (PCV10) and 13-valent (PCV13) vaccines in 10 countries in Europe.
G. Hanquet +29 more
semanticscholar +1 more source